Rhode Island House Bill H8360

Rhode Island 2026 Regular Session

• Introduced: 3/27/26
• Refer: 3/27/26

Caption

Provides that certain actions taken by pharmacy benefits managers are deceptive or unfair trade practices.

Impact

If enacted, this bill would impose significant changes to the operations of pharmacy benefits managers within the state. It would explicitly make certain practices illegal, thereby enhancing protections for consumers and pharmacists against potential exploitation or unfair treatment. For instance, it prohibits practices like patient steering to affiliated pharmacies and would place limitations on the pricing strategies employed by PBMs, seeking to create a more transparent environment where the interests of consumers are prioritized over profit-driven motives of the PBM industry.

Summary

H8360 is a legislative act proposed to amend Chapter 6-13.1 of the General Laws concerning deceptive trade practices, specifically targeting pharmacy benefits managers (PBMs). The bill aims to establish that certain actions taken by PBMs constitute unfair and deceptive practices. Among these actions are spread pricing and effective rate pricing, as well as a range of practices that could manipulate or influence patient choices and pharmacy functions detrimental to patients and pharmacists alike. The introduction of this bill reflects an effort to regulate the pharmaceutical landscape and address prevailing concerns about the conduct of PBMs in the state of Rhode Island.

Contention

The discussion surrounding H8360 is likely to reflect a division between the interests of PBMs, which might argue that such regulations could hinder their business models and potentially increase costs for consumers, and advocates for the bill who contend that the current practices often lead to deceptive pricing and restrict consumer choice. Critics of the bill may argue that it introduces too much regulatory oversight, potentially limiting the flexibility needed in the rapidly changing healthcare market. However, supporters emphasize the necessity of protecting the integrity of the pharmacy sector and ensuring that patients receive fair treatment.

Additional_points

Furthermore, the bill outlines a series of provisions that will define specific behaviors as unfair trade practices, categorizing consecutive violations per consumer transaction. It also contains a clause emphasizing the necessity for PBMs to operate with proper registration in the state. H8360 not only seeks to clarify existing laws but aims at establishing a legal framework that enhances overall accountability and transparency within the healthcare system, particularly concerning pharmaceutical pricing and patient care.